CREATE
TRANSFORMATIVE
MEDICINES
TRANSFORMATIVE
MEDICINES
A global leader in innovative solutions for the discovery, development, and manufacture of novel nanoparticle medicines.
Every Stage
of Development
of Development
Come find us at Booth #403 for the official commercial launch of NxGen Blaze and NxGen Blaze+ at the 2019 CRS Annual Meeting & Exposition July 21st - 24th in Valencia, Spain.
The proprietary NxGen microfluidic mixer platform is designed exclusively for scalable development of nanomedicines from bench to bedside. The Blaze instrument has been reengineered to integrate the NxGen microfluidic mixer platform. The NxGen Blaze and NxGen Blaze+ enable development of nanomedicines faster and for lower cost.
Talk to our experts at Booth #403 to learn more about NxGen Blaze and NxGen Blaze+ and our other innovative solutions for the discovery, development, and manufacture of transformative medicines. We provide a wide range of expertise in formulation and clinical solutions, a proprietary platform and reagents.
Also, Join our Experts for the Following Presentations
Sunday, July 21 9:00am - 11:30am | CRS 2019 Industry Soapbox
|
Tuesday, July 23 1:30pm - 3:30pm | Panel Discussion Session 9: New Approaches on Physio-Chemical Characterization, Scale-Up and Stability Studies
Presentation Time: 2:20 pm - 2:30 pm
Presentation Topic: Scalable Manufacture Of mRNA Lipid Nanoparticles Using A Novel Microfluidic Mixing Architecture |
Rapidly prepare low-volume nanoparticle formulations with the push of a button on the Spark™ or learn how Formulation Solutions can help with proof-of-concept nanoparticle formulations.
Optimize a wide range of nanomedicine formulations with the NanoAssemblr® Benchtop or
the Blaze™
depending on your volumes to allow you to gather the data on the effectiveness, required dosing and safety of a new therapy.
Scalable manufacturing is a significant challenge to making revolutionary medicine and Clinical Solution is ready to assist you in your nanoparticle manufacturing process development.
Get Started
To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.
Technology
Our technology provides a seamless path forward to larger experimental studies, all the way to the clinic: low volume prototype formulations are easily scaled-up using larger instruments of the NanoAssemblr® family, which provides microfluidic mixing and manufacturing of nanoparticles.
Areas of Interest
Nanomedicines span many areas of interest. Explore resourceslike papers, application notes, scientific posters, webinars and more to see how nanotechnology is transforming medicine.
over
70%
of top pharmaceutical companies work with PNI
200+
instruments are installed
worldwide
80+
biopharmaceutical labs use NanoAssemblr® instruments for nanomedicine
drug development
Innovations that accelerate the drug development journey and enable the production of more sophisticated and powerful nanomedicines is our passion. We don’t do it alone, we pursue strategic collaborations that enable researchers to move quickly
in the drug development process. Contact our Business Development Team.
PNI Feature in BioWorld
"As we bite off different problems and succeed on those, we can leverage those technologies," CEO Taylor explains. "We like to think that we're democratizing and lowering the barrier for people to get into these important technologies."
Evonik Collaboration
PNI announces a manufacturing collaboration agreement with Evonik for the tech transfer of the NanoAssemblr® system to Evonik Canada for late-stage clinical research.
License Agreement with Entos Pharmaceuticals
Precision NanoSystems and Entos Pharmaceuticals sign license agreement for the use of the NanoAssemblr® platform for scale-up and GMP manufacturing of nanomedicines.
Upcoming Events See All
September
09 - 10
2019
American DDF Summit
Held in Boston, American DDF Summit brings innovative solutions to the greatest challenges in pharmaceutical development. Covering both small molecules and biologics, you’ll be able find new technologies,concepts and case studies in areas such as formulation design for po...
September
15 - 18
2019
Liposome Research Days 2019
We invite you to join us at the Liposome Research Days (LRD) 2019! The LRD Conferences focus on lipid-containing structures from basic studies, such as the physicochemical properties of liposomes, to clinical applications of drug delivery systems (DDS). Attendees come from all ov...
September
22 - 24
2019
NanoDDS
Hosted at the Massachusetts University of Technology, NanoDDS highlights new groundbreaking discoveries and developments in nanomedicine and drug delivery. Revolutionary advances in this area require collaboration among researchers working in a diverse array of fields including ...
Resource Center
Publication - Summary
May 18, 2019
Annals of Hematology
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo
Read MorePublication - Summary
May 17, 2019
Science Immunology
A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
Read MorePublication - Summary
April 04, 2019
The Journal of Neuroscience
PTCD1 is required for mitochondrial oxidative-phosphorylation: possible genetic association with Alzheimer's disease
Read MorePublication - Summary
February 07, 2019
Nano Research
Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast can...
Read MoreApplication Note
January 16, 2019
mRNA Lipid Nanoparticles: Robust low-volume production for screening high-value nanoparticle materials
Read More
Publication - Summary
September 24, 2018
Nucleic Acid Therapeutics
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
Read MoreStay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.
MENU
